 | • レポートコード：MRC2304J0177 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、247ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、世界の生物学データ可視化市場規模は、2021年872.78百万ドルから2022年に989.67百万ドルへと拡大、その後2027年までに年平均13.56％成長して1,872.76百万ドルに達する見通しです。本書は、生物学データ可視化の世界市場を対象とした調査・分析結果を整理したものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別分析（MRI、顕微鏡検査、シーケンシング、X線結晶）、プラットフォーム別分析（Linux、MacOS、Windows）、用途別分析（アラインメント・系統発生・進化、細胞・生物イメージング、ゲノム解析、構造生物学・分子モデリング、システム生物学）、エンドユーザー別分析（学術研究、病院＆クリニック、製薬＆バイオテクノロジー企業）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目を掲載しています。なお、本書には、3M、Advanced Visual Systems, Inc.、Agilent Technologies、arivis AG、Becton, Dickinson and Company (BD)、Carl Zeiss AG、Clarivate Analytics、Danaher、Genedata AG、Genialis, Inc.、IMSTAR S.A.、Media Cybernetics, Inc.、OLYMPUS CORPORATIONなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の生物学データ可視化市場規模：技術別 - MRIの市場規模 - 顕微鏡検査の市場規模 - シーケンシングの市場規模 - X線結晶の市場規模 ・世界の生物学データ可視化市場規模：プラットフォーム別 - Linuxの市場規模 - MacOSの市場規模 - Windowsの市場規模 ・世界の生物学データ可視化市場規模：用途別 - アラインメント・系統発生・進化における市場規模 - 細胞・生物イメージングにおける市場規模 - ゲノム解析における市場規模 - 構造生物学・分子モデリングにおける市場規模 - システム生物学における市場規模 ・世界の生物学データ可視化市場規模：エンドユーザー別 - 学術研究における市場規模 - 病院＆クリニックにおける市場規模 - 製薬＆バイオテクノロジー企業における市場規模 ・世界の生物学データ可視化市場規模：地域別 - 南北アメリカの生物学データ可視化市場規模 アメリカの生物学データ可視化市場規模 カナダの生物学データ可視化市場規模 ブラジルの生物学データ可視化市場規模 ... - アジア太平洋の生物学データ可視化市場規模 日本の生物学データ可視化市場規模 中国の生物学データ可視化市場規模 インドの生物学データ可視化市場規模 韓国の生物学データ可視化市場規模 台湾の生物学データ可視化市場規模 ... - ヨーロッパ/中東/アフリカの生物学データ可視化市場規模 イギリスの生物学データ可視化市場規模 ドイツの生物学データ可視化市場規模 フランスの生物学データ可視化市場規模 ロシアの生物学データ可視化市場規模 ... - その他地域の生物学データ可視化市場規模 ・競争状況 ・企業情報 |
The Global Biological Data Visualization Market size was estimated at USD 872.78 million in 2021 and expected to reach USD 989.67 million in 2022, and is projected to grow at a CAGR 13.56% to reach USD 1,872.76 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Biological Data Visualization to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the market was studied across Magnetic Resonance Imaging, Microscopy, Sequencing, and X-ray Crystallography.
Based on Platform, the market was studied across Linux, Mac OS, and Windows.
Based on Application, the market was studied across Alignments, Phylogeny, and Evolution, Cell and Organism Imaging, Genomic Analysis, Structural Biology and Molecular Modeling, and Systems Biology.
Based on End User, the market was studied across Academic Research, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biological Data Visualization market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biological Data Visualization Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biological Data Visualization Market, including 3M, Advanced Visual Systems, Inc., Agilent Technologies, arivis AG, Becton, Dickinson and Company (BD), Carl Zeiss AG, Clarivate Analytics, Danaher, Genedata AG, Genialis, Inc., IMSTAR S.A., Media Cybernetics, Inc., Molecular Devices, LLC, OLYMPUS CORPORATION, Oxford Instruments, Plotly, QIAGEN, Quorum Technologies Ltd., Scientific Volume Imaging B.V., and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biological Data Visualization Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biological Data Visualization Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biological Data Visualization Market?
4. What is the competitive strategic window for opportunities in the Global Biological Data Visualization Market?
5. What are the technology trends and regulatory frameworks in the Global Biological Data Visualization Market?
6. What is the market share of the leading vendors in the Global Biological Data Visualization Market?
7. What modes and strategic moves are considered suitable for entering the Global Biological Data Visualization Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Demand to derive significant data from chunks of unorganized data in short period of time
5.1.1.2. Increasing use of advanced analytical tools to hasten the process of decision-making
5.1.1.3. Integration of virtual reality technology in healthcare industry
5.1.2. Restraints
5.1.2.1. Non-availability of computational regularity
5.1.3. Opportunities
5.1.3.1. Growth in data mining has increased the utilization of visualization tools for analyzing genomic and proteomic data
5.1.3.2. Adoption of artificial intelligence and IoT in big data analytics of biomedical field
5.1.4. Challenges
5.1.4.1. Problems pertinent to user interface
5.2. Cumulative Impact of COVID-19
6. Biological Data Visualization Market, by Technology
6.1. Introduction
6.2. Magnetic Resonance Imaging
6.3. Microscopy
6.4. Sequencing
6.5. X-ray Crystallography
7. Biological Data Visualization Market, by Platform
7.1. Introduction
7.2. Linux
7.3. Mac OS
7.4. Windows
8. Biological Data Visualization Market, by Application
8.1. Introduction
8.2. Alignments, Phylogeny, and Evolution
8.3. Cell and Organism Imaging
8.4. Genomic Analysis
8.5. Structural Biology and Molecular Modeling
8.6. Systems Biology
9. Biological Data Visualization Market, by End User
9.1. Introduction
9.2. Academic Research
9.3. Hospitals & Clinics
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Biological Data Visualization Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biological Data Visualization Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Biological Data Visualization Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 3M
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Advanced Visual Systems, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Agilent Technologies
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. arivis AG
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Becton, Dickinson and Company (BD)
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Carl Zeiss AG
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Clarivate Analytics
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Danaher
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Genedata AG
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Genialis, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. IMSTAR S.A.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Media Cybernetics, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Molecular Devices, LLC
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. OLYMPUS CORPORATION
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Oxford Instruments
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Plotly
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. QIAGEN
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Quorum Technologies Ltd.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Scientific Volume Imaging B.V.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Thermo Fisher Scientific, Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing